Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1373 ARTÍCULOS , VIENDO DEL 166 AL 180

Comparison of ELISA measurements of anti-Aβ concentrations and percentages of specific binding to Aβ between unfractionated intravenous immunoglobulin products and their purified anti-Aβ antibodies

Klaver AC, Coffey MP, Smith LM, Loeffler DA.

Immunol Lett. 2013 Jul-Aug;154(1-2):7-11. doi: 10.1016/j.imlet.2013.07.008. Epub 2013 Aug 6.

Assessment of socioemotional processes facilitates the distinction between frontotemporal lobar degeneration and Alzheimer's disease

Narme P, Mouras H, Roussel M, Devendeville A, Godefroy O.

J Clin Exp Neuropsychol. 2013;35(7):728-44. doi: 10.1080/13803395.2013.823911. Epub 2013 Aug 12.

Neuroprotective properties of curcumin in Alzheimer's disease--merits and limitations

Chin D, Huebbe P, Pallauf K, Rimbach G.

Curr Med Chem. 2013;20(32):3955-85. doi: 10.2174/09298673113209990210.

The multifactorial nature of Alzheimer's disease for developing potential therapeutics

Carreiras MC, Mendes E, Perry MJ, Francisco AP, Marco-Contelles J.

Curr Top Med Chem. 2013;13(15):1745-70. doi: 10.2174/15680266113139990135.

Emerging targets in neurodegeneration: new opportunities for Alzheimer's disease treatment?

Rampa A, Gobbi S, Belluti F, Bisi A.

Curr Top Med Chem. 2013;13(15):1879-904. doi: 10.2174/15680266113139990143.

Natural products as sources of new lead compounds for the treatment of Alzheimer's disease

Huang L, Su T, Li X.

Curr Top Med Chem. 2013;13(15):1864-78. doi: 10.2174/15680266113139990142.

From the multifactorial nature of Alzheimer`s disease to multitarget therapy: the contribution of the translational approach

Calzà L, Baldassarro VA, Giuliani A, Lorenzini L, Fernandez M, Mangano C, Sivilia S, Alessandri M, Gusciglio M, Torricella R, Giardino L.

Curr Top Med Chem. 2013;13(15):1843-52. doi: 10.2174/15680266113139990140.

Dual inhibitors of β-amyloid aggregation and acetylcholinesterase as multi-target anti-Alzheimer drug candidates

Viayna E, Sabate R, Muñoz-Torrero D.

Curr Top Med Chem. 2013;13(15):1820-42. doi: 10.2174/15680266113139990139.

Lessons learnt from glycogen synthase kinase 3 inhibitors development for Alzheimer's disease

Martinez A, Perez DI, Gil C.

Curr Top Med Chem. 2013;13(15):1808-19. doi: 10.2174/15680266113139990138.

The structural evolution of β-secretase inhibitors: a focus on the development of small-molecule inhibitors

Butini S, Brogi S, Novellino E, Campiani G, Ghosh AK, Brindisi M, Gemma S.

Curr Top Med Chem. 2013;13(15):1787-807. doi: 10.2174/15680266113139990137.

Multifunctional tacrine derivatives in Alzheimer's disease

Minarini A, Milelli A, Simoni E, Rosini M, Bolognesi ML, Marchetti C, Tumiatti V.

Curr Top Med Chem. 2013;13(15):1771-86. doi: 10.2174/15680266113139990136.

New approaches to the treatment of Alzheimer's disease

Rampa A, Bisi A.

Curr Top Med Chem. 2013;13(15):1743-4. doi: 10.2174/15680266113139990134.

Phosphorylation of tau protein as the link between oxidative stress, mitochondrial dysfunction, and connectivity failure: implications for Alzheimer's disease

Mondragón-Rodríguez S, Perry G, Zhu X, Moreira PI, Acevedo-Aquino MC, Williams S.

Oxid Med Cell Longev. 2013;2013:940603. doi: 10.1155/2013/940603. Epub 2013 Jul 10.

Successes and failures for drugs in late-stage development for Alzheimer's disease

Berk C, Sabbagh MN.

Drugs Aging. 2013 Oct;30(10):783-92. doi: 10.1007/s40266-013-0108-6.

Effect of the timing of acetylcholinesterase inhibitor ingestion on sleep

Song HR, Woo YS, Wang HR, Jun TY, Bahk WM.

Int Clin Psychopharmacol. 2013 Nov;28(6):346-8. doi: 10.1097/YIC.0b013e328364f58d.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias